The first Biocept trade was made in Q3 2020.
Since then Jim Simons bought shares five more times and sold shares on four occasions. The investor sold all their shares in Q2 2023 and doesn't own any shares in Biocept anymore.
Avg closing price
Price range
Sold -6.46 Thousand shares
Q2 2023
Avg closing price
$1.39
Price range
$0.21
-
$6.65
Increased shares by 19.4% (+1.05 Thousand shares)
Q1 2023
Avg closing price
$0.48
Price range
$0.24
-
$0.62
Sold 3.6% shares (-203 shares)
Q4 2022
Avg closing price
$0.74
Price range
$0.47
-
$0.93
Sold 4.0% shares (-235 shares)
Q3 2022
Avg closing price
$0.99
Price range
$0.75
-
$1.20
Increased shares by 50.8% (+1.97 Thousand shares)
Q2 2022
Avg closing price
$1.52
Price range
$0.88
-
$2.27
Increased shares by 27.1% (+826 shares)
Q1 2022
Avg closing price
$2.62
Price range
$1.83
-
$3.97
Increased shares by 80.3% (+1.36 Thousand shares)
Q4 2021